A selected collection of research and public health guidance, with short explanations to help you explore claims about autism and children’s health.
Educational information, not individual medical advice. Sudden or severe new symptoms need clinical assessment.
8 resources shown
A clear starting point: autism affects how people experience the world, communicate and process sensory information. Support needs differ between people.
Useful for an accessible overview, rather than an individual assessment.
Read the sourceThis review found no increased autism risk associated with MMR vaccination. The autism analysis included two observational studies involving 1,194,764 children.
A synthesis of research; the autism-specific evidence was rated moderate certainty.
Read the sourceThe Danish study found no increased autism risk after MMR vaccination, including in the higher-risk subgroups examined.
Large observational study. Size is valuable, but observational research still has limitations.
Read the sourceThe review found no clinical trial evidence that chelation treats autism, and highlighted potentially serious harms.
An older review with limited trial evidence; read alongside the FDA safety information below.
Read the sourceThe FDA warns about unapproved chelation products, including risks of kidney failure and death. Medically supervised treatment for diagnosed poisoning is a different situation.
Autism alone does not establish heavy-metal poisoning or a need for chelation.
Read the sourceThese conditions involve sudden neuropsychiatric symptoms. They are not another name for autism. Diagnosis requires careful assessment; no single laboratory test confirms them.
New, severe OCD symptoms or restricted eating deserve medical assessment; do not diagnose from a social post.
Read the sourceCheck who wrote it, who funds it, the evidence behind it and when it was updated. A testimonial or a confident video is not a clinical study.
Start here when a post promises a cure or uses a study headline to sell a product.
Read the sourceVitamin K is offered to help prevent a rare bleeding disorder in newborn babies. This NHS guide explains what happens after birth.
Discuss the available options and follow-up doses with your midwife or neonatal team.
Read the sourceNo matching resources. Try another topic or clear your search.
Sources are selected for relevance, transparent methods and clear authorship. Reviews, individual studies and patient guidance are labelled separately. Publication dates matter: older work is identified rather than presented as new. Our summaries are available in three languages; external sources may be in English. Inclusion is not endorsement of everything on an external website.
Sources checked: 17 October 2026. This is a dated selection, not a live monitoring service.
Suggest a topic or report a correction